Literature DB >> 21583656

4-(4-Bromo-phen-yl)-5-oxo-1,2,3,4,5,6,7,8-octa-hydro-quinazoline-2-thione.

Min Xie1, Changquan Deng, Jie Zheng, Yulin Zhu.   

Abstract

The title compound, C(14)H(13)BrN(2)OS, was synthesized from the multicomponent reaction between thio-urea, 4-bromo-benzaldehyde and cyclo-hexane-1,3-dione. The crystal packing is stabilized by inter-molecular N-H⋯O, N-H⋯S, C-H⋯O and C-H⋯S hydrogen bonds. Br⋯O inter-actions [3.183 (3) Å] are also observed in the crystal structure.

Entities:  

Year:  2009        PMID: 21583656      PMCID: PMC2977462          DOI: 10.1107/S1600536809028761

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the pharmaceutical applications of 4-aryl-5-oxo-1,2,3,4,5,6,7,8-octa­hydro­quinazoline-2-thio­nes, see: Kappe & Stadler (2004 ▶); Sarac et al. (1997 ▶, 1999 ▶); Yarima et al., (2003 ▶). For background information on halogen bonding, see: Damodharana et al. (2004 ▶); Sureshan et al. (2001 ▶); Yang et al. (2008 ▶).

Experimental

Crystal data

C14H13BrN2OS M = 337.23 Triclinic, a = 7.0395 (11) Å b = 8.1859 (13) Å c = 13.286 (2) Å α = 105.329 (2)° β = 91.279 (2)° γ = 103.854 (2)° V = 713.9 (2) Å3 Z = 2 Mo Kα radiation μ = 3.02 mm−1 T = 293 K 0.25 × 0.25 × 0.20 mm

Data collection

Bruker APEXII area-detector diffractometer Absorption correction: multi-scan (SADABS; Bruker, 2004 ▶) T min = 0.429, T max = 0.547 3953 measured reflections 2744 independent reflections 1880 reflections with I > 2σ(I) R int = 0.021

Refinement

R[F 2 > 2σ(F 2)] = 0.046 wR(F 2) = 0.117 S = 1.04 2744 reflections 174 parameters H-atom parameters constrained Δρmax = 0.42 e Å−3 Δρmin = −0.60 e Å−3 Data collection: APEX2 (Bruker, 2004 ▶); cell refinement: SAINT (Bruker, 2004 ▶); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: SHELXTL (Sheldrick, 2008 ▶); software used to prepare material for publication: SHELXTL. Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536809028761/zl2225sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536809028761/zl2225Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C14H13BrN2OSZ = 2
Mr = 337.23F(000) = 340
Triclinic, P1Dx = 1.569 Mg m3
Hall symbol: -P 1Mo Kα radiation, λ = 0.71073 Å
a = 7.0395 (11) ÅCell parameters from 1089 reflections
b = 8.1859 (13) Åθ = 2.7–23.6°
c = 13.286 (2) ŵ = 3.02 mm1
α = 105.329 (2)°T = 293 K
β = 91.279 (2)°Block, colourless
γ = 103.854 (2)°0.25 × 0.25 × 0.20 mm
V = 713.9 (2) Å3
Bruker APEXII area-detector diffractometer2744 independent reflections
Radiation source: fine-focus sealed tube1880 reflections with I > 2σ(I)
graphiteRint = 0.021
φ and ω scansθmax = 26.0°, θmin = 1.6°
Absorption correction: multi-scan (APEX2; Bruker, 2004)h = −8→8
Tmin = 0.429, Tmax = 0.547k = −10→10
3953 measured reflectionsl = −16→16
Refinement on F2Secondary atom site location: difference Fourier map
Least-squares matrix: fullHydrogen site location: inferred from neighbouring sites
R[F2 > 2σ(F2)] = 0.046H-atom parameters constrained
wR(F2) = 0.117w = 1/[σ2(Fo2) + (0.0382P)2 + 0.8552P] where P = (Fo2 + 2Fc2)/3
S = 1.04(Δ/σ)max < 0.001
2744 reflectionsΔρmax = 0.42 e Å3
174 parametersΔρmin = −0.60 e Å3
0 restraintsExtinction correction: SHELXL97 (Sheldrick, 2008), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
Primary atom site location: structure-invariant direct methodsExtinction coefficient: 0.0058 (17)
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > 2sigma(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
Br10.08077 (11)0.17375 (8)−0.08352 (4)0.0927 (3)
S10.81565 (14)0.62120 (13)0.47136 (8)0.0395 (3)
N20.4706 (4)0.6637 (4)0.4168 (2)0.0322 (7)
H20.42230.60000.45680.039*
C80.6646 (5)0.7134 (5)0.4188 (3)0.0294 (8)
C70.3316 (5)0.7096 (4)0.3511 (3)0.0291 (8)
H70.21390.71760.38810.035*
C60.4253 (5)0.8861 (4)0.3369 (3)0.0282 (8)
C50.6241 (5)0.9449 (4)0.3455 (3)0.0287 (8)
C10.3007 (5)0.9915 (4)0.3130 (3)0.0303 (8)
C40.7274 (5)1.1109 (5)0.3220 (3)0.0352 (9)
H4A0.84751.09640.29060.042*
H4B0.76261.20470.38670.042*
C20.3965 (5)1.1566 (5)0.2867 (3)0.0396 (9)
H2A0.40841.25470.34840.047*
H2B0.31291.17220.23280.047*
C30.5987 (5)1.1589 (5)0.2486 (3)0.0402 (9)
H3A0.58511.07680.17960.048*
H3B0.66061.27490.24260.048*
N10.7383 (4)0.8485 (4)0.3772 (2)0.0350 (7)
H10.86220.87510.37030.042*
C90.2714 (5)0.5708 (4)0.2475 (3)0.0321 (8)
C120.1586 (8)0.3298 (5)0.0523 (3)0.0557 (12)
C140.0763 (6)0.4943 (6)0.2134 (4)0.0598 (13)
H14−0.01970.52400.25640.072*
C100.4095 (6)0.5213 (6)0.1814 (3)0.0482 (11)
H100.54240.57040.20270.058*
C110.3538 (7)0.4003 (6)0.0842 (3)0.0545 (12)
H110.44830.36740.04110.065*
C130.0205 (8)0.3738 (7)0.1163 (4)0.0802 (18)
H13−0.11200.32280.09470.096*
O10.1229 (4)0.9472 (3)0.3167 (2)0.0426 (7)
U11U22U33U12U13U23
Br10.1179 (6)0.0830 (5)0.0453 (3)−0.0032 (4)0.0010 (3)−0.0098 (3)
S10.0319 (6)0.0473 (6)0.0477 (6)0.0135 (4)0.0060 (4)0.0239 (5)
N20.0243 (17)0.0368 (17)0.0377 (17)0.0038 (13)0.0046 (13)0.0172 (14)
C80.027 (2)0.036 (2)0.0277 (18)0.0093 (16)0.0019 (14)0.0123 (15)
C70.0207 (18)0.0322 (19)0.0358 (19)0.0052 (15)0.0042 (15)0.0127 (15)
C60.0252 (19)0.0285 (18)0.0306 (18)0.0044 (15)0.0049 (14)0.0099 (14)
C50.0245 (19)0.0284 (18)0.0348 (19)0.0065 (15)0.0069 (15)0.0114 (15)
C10.026 (2)0.0326 (19)0.0319 (19)0.0073 (15)0.0046 (15)0.0079 (15)
C40.026 (2)0.031 (2)0.050 (2)0.0026 (16)0.0055 (17)0.0165 (17)
C20.030 (2)0.039 (2)0.053 (2)0.0100 (17)0.0058 (18)0.0179 (18)
C30.034 (2)0.041 (2)0.051 (2)0.0052 (18)0.0070 (18)0.0251 (19)
N10.0208 (16)0.0410 (18)0.0496 (19)0.0077 (13)0.0072 (14)0.0231 (15)
C90.030 (2)0.0297 (19)0.038 (2)0.0042 (16)0.0037 (16)0.0161 (16)
C120.073 (3)0.040 (2)0.041 (2)−0.003 (2)0.007 (2)0.0044 (19)
C140.034 (2)0.074 (3)0.050 (3)−0.002 (2)0.006 (2)−0.003 (2)
C100.037 (2)0.054 (3)0.049 (3)0.010 (2)0.0076 (19)0.008 (2)
C110.067 (3)0.051 (3)0.044 (3)0.014 (2)0.015 (2)0.010 (2)
C130.045 (3)0.092 (4)0.064 (3)−0.013 (3)0.000 (3)−0.017 (3)
O10.0251 (15)0.0507 (17)0.0573 (18)0.0117 (12)0.0069 (12)0.0221 (14)
Br1—C121.895 (4)C4—H4B0.9700
Br1—O1i3.183 (3)C2—C31.519 (5)
S1—C81.678 (4)C2—H2A0.9700
N2—C81.326 (4)C2—H2B0.9700
N2—C71.474 (4)C3—H3A0.9700
N2—H20.8600C3—H3B0.9700
C8—N11.364 (4)N1—H10.8600
C7—C61.500 (5)C9—C141.376 (5)
C7—C91.510 (5)C9—C101.386 (5)
C7—H70.9800C12—C131.356 (6)
C6—C51.358 (5)C12—C111.366 (7)
C6—C11.453 (5)C14—C131.383 (6)
C5—N11.382 (4)C14—H140.9300
C5—C41.495 (5)C10—C111.384 (6)
C1—O11.222 (4)C10—H100.9300
C1—C21.492 (5)C11—H110.9300
C4—C31.504 (5)C13—H130.9300
C4—H4A0.9700
C12—Br1—O1i154.81 (16)C1—C2—H2B108.9
C8—N2—C7124.8 (3)C3—C2—H2B108.9
C8—N2—H2117.6H2A—C2—H2B107.7
C7—N2—H2117.6C4—C3—C2111.6 (3)
N2—C8—N1116.3 (3)C4—C3—H3A109.3
N2—C8—S1123.1 (3)C2—C3—H3A109.3
N1—C8—S1120.6 (3)C4—C3—H3B109.3
N2—C7—C6108.5 (3)C2—C3—H3B109.3
N2—C7—C9111.0 (3)H3A—C3—H3B108.0
C6—C7—C9112.0 (3)C8—N1—C5123.3 (3)
N2—C7—H7108.4C8—N1—H1118.3
C6—C7—H7108.4C5—N1—H1118.3
C9—C7—H7108.4C14—C9—C10117.5 (4)
C5—C6—C1120.8 (3)C14—C9—C7121.0 (3)
C5—C6—C7120.1 (3)C10—C9—C7121.4 (3)
C1—C6—C7119.1 (3)C13—C12—C11120.5 (4)
C6—C5—N1119.4 (3)C13—C12—Br1119.9 (4)
C6—C5—C4122.9 (3)C11—C12—Br1119.6 (3)
N1—C5—C4117.7 (3)C9—C14—C13121.1 (4)
O1—C1—C6120.6 (3)C9—C14—H14119.4
O1—C1—C2121.3 (3)C13—C14—H14119.4
C6—C1—C2118.1 (3)C11—C10—C9121.4 (4)
C5—C4—C3110.8 (3)C11—C10—H10119.3
C5—C4—H4A109.5C9—C10—H10119.3
C3—C4—H4A109.5C12—C11—C10119.3 (4)
C5—C4—H4B109.5C12—C11—H11120.3
C3—C4—H4B109.5C10—C11—H11120.3
H4A—C4—H4B108.1C12—C13—C14120.2 (5)
C1—C2—C3113.4 (3)C12—C13—H13119.9
C1—C2—H2A108.9C14—C13—H13119.9
C3—C2—H2A108.9
C7—N2—C8—N116.5 (5)C1—C2—C3—C4−50.8 (5)
C7—N2—C8—S1−164.9 (3)N2—C8—N1—C57.6 (5)
C8—N2—C7—C6−31.3 (4)S1—C8—N1—C5−171.1 (3)
C8—N2—C7—C992.1 (4)C6—C5—N1—C8−12.3 (5)
N2—C7—C6—C524.8 (4)C4—C5—N1—C8167.8 (3)
C9—C7—C6—C5−98.0 (4)N2—C7—C9—C14126.7 (4)
N2—C7—C6—C1−155.8 (3)C6—C7—C9—C14−111.9 (4)
C9—C7—C6—C181.3 (4)N2—C7—C9—C10−56.1 (4)
C1—C6—C5—N1174.5 (3)C6—C7—C9—C1065.3 (4)
C7—C6—C5—N1−6.1 (5)O1i—Br1—C12—C1363.0 (6)
C1—C6—C5—C4−5.6 (5)O1i—Br1—C12—C11−115.5 (5)
C7—C6—C5—C4173.8 (3)C10—C9—C14—C13−0.7 (7)
C5—C6—C1—O1−171.9 (3)C7—C9—C14—C13176.6 (5)
C7—C6—C1—O18.8 (5)C14—C9—C10—C110.5 (6)
C5—C6—C1—C26.5 (5)C7—C9—C10—C11−176.8 (4)
C7—C6—C1—C2−172.9 (3)C13—C12—C11—C10−1.9 (7)
C6—C5—C4—C3−23.7 (5)Br1—C12—C11—C10176.6 (3)
N1—C5—C4—C3156.2 (3)C9—C10—C11—C120.8 (7)
O1—C1—C2—C3−159.6 (4)C11—C12—C13—C141.8 (9)
C6—C1—C2—C322.0 (5)Br1—C12—C13—C14−176.8 (4)
C5—C4—C3—C250.7 (4)C9—C14—C13—C12−0.4 (9)
D—H···AD—HH···AD···AD—H···A
C2—H2A···S1ii0.972.983.781 (4)140
N2—H2···S1iii0.862.553.380 (3)161
N1—H1···O1iv0.862.002.832 (4)164
C4—H4A···O1iv0.972.593.361 (4)137
Table 1

Hydrogen-bond geometry (Å, °)

D—H⋯AD—HH⋯ADAD—H⋯A
C2—H2A⋯S1i0.972.983.781 (4)140
N2—H2⋯S1ii0.862.553.380 (3)161
N1—H1⋯O1iii0.862.002.832 (4)164
C4—H4A⋯O1iii0.972.593.361 (4)137

Symmetry codes: (i) ; (ii) ; (iii) .

  3 in total

1.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

2.  4-aryl-5-oxo-1,2,3,4,5,6,7,8-octahydroquinazoline-2-thione derivatives: synthesis, enantiomeric separation and in vitro screening as calcium antagonists.

Authors:  S Saraç; M Yarim; M Ertan; K Erol; Y Aktan
Journal:  Boll Chim Farm       Date:  1997-12

3.  Synthesis and in vitro calcium antagonist activity of 4-aryl-7,7-dimethyl/1,7,7-trimethyl-1,2,3,4,5,6,7,8-octahydroquinazoline-2,5-dione derivatives.

Authors:  Mine Yarim; Selma Saraç; F Sultan Kiliç; Kevser Erol
Journal:  Farmaco       Date:  2003-01
  3 in total
  1 in total

1.  2-Bromo-3-nitro-benzaldehyde.

Authors:  Vijay P Singh; Harkesh B Singh; Ray J Butcher
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-10-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.